Article
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
PloS one - 1 Jan 2015
Chen Yu-Mu, Lai Chien-Hao, Chang Huang-Chih, Chao Tung-Ying, Tseng Chia-Cheng, Fang Wen-Feng, Wang Chin-Chou, Chung Yu-Hsiu, Wang Yi-Hsi, Su Mao-Chang, Huang Kuo-Tung, Chen Hung-Chen, Chang Ya-Chun, Lin Meng-Chih
Abstract excerpt
BACKGROUND: Patients with early-stage lung cancer who have a high baseline lymphocyte-to-monocyte ratio (LMR) have a favorable prognosis. However, the prognostic significance of LMR in patients with advanced-stage EGFR-mutant non-small cell lung cancer (NSCLC) receiving first-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) has not been established. We conducted a retrospective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.